Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
The medication lowers blood sugar levels effectively when used according to the FDA-recommended dosing schedule and by administering FDA-approved doses (0.25 mg, 0.5 mg, 1 mg, and 2 mg)
The evidence base for Wegovy's safety profile comes primarily from the STEP (Semaglutide Treatment Effect in People with obesity) clinical trial programme, which evaluated semaglutide 2.4 mg in diverse populations over 68 weeks
The results were highly significant and dose-dependent
This is why an infusion should be given in a medical facility, from a ready-made preparation and under the supervision of staff
Look out for signs like dark urine, dizziness, thirst, a dry mouth, or unusual fatigue, and seek medical advice if they occur
